China Antiretroviral Therapy Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Antiretroviral Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Antiretroviral Therapy Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Antiretroviral Therapy Overall Market Size
2.1 China Antiretroviral Therapy Market Size: 2021 VS 2027
2.2 China Antiretroviral Therapy Revenue, Prospects & Forecasts: 2016-2027
2.3 China Antiretroviral Therapy Sales: 2016-2027
3 Company Landscape
3.1 Top Antiretroviral Therapy Players in China Market
3.2 Top China Antiretroviral Therapy Companies Ranked by Revenue
3.3 China Antiretroviral Therapy Revenue by Companies
3.4 China Antiretroviral Therapy Sales by Companies
3.5 China Antiretroviral Therapy Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antiretroviral Therapy Companies in China Market, by Revenue in 2020
3.7 Manufacturers Antiretroviral Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antiretroviral Therapy Players in China Market
3.8.1 List of Tier 1 Antiretroviral Therapy Companies in China
3.8.2 List of Tier 2 and Tier 3 Antiretroviral Therapy Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Antiretroviral Therapy Market Size Markets, 2021 & 2027
4.1.2 NNRTIs
4.1.3 NRTI
4.1.4 Multiclass Combination Products
4.1.5 Integrase Inhibitors
4.2 By Type - China Antiretroviral Therapy Revenue & Forecasts
4.2.1 By Type - China Antiretroviral Therapy Revenue, 2016-2021
4.2.2 By Type - China Antiretroviral Therapy Revenue, 2022-2027
4.2.3 By Type - China Antiretroviral Therapy Revenue Market Share, 2016-2027
4.3 By Type - China Antiretroviral Therapy Sales & Forecasts
4.3.1 By Type - China Antiretroviral Therapy Sales, 2016-2021
4.3.2 By Type - China Antiretroviral Therapy Sales, 2022-2027
4.3.3 By Type - China Antiretroviral Therapy Sales Market Share, 2016-2027
4.4 By Type - China Antiretroviral Therapy Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Antiretroviral Therapy Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - China Antiretroviral Therapy Revenue & Forecasts
5.2.1 By Application - China Antiretroviral Therapy Revenue, 2016-2021
5.2.2 By Application - China Antiretroviral Therapy Revenue, 2022-2027
5.2.3 By Application - China Antiretroviral Therapy Revenue Market Share, 2016-2027
5.3 By Application - China Antiretroviral Therapy Sales & Forecasts
5.3.1 By Application - China Antiretroviral Therapy Sales, 2016-2021
5.3.2 By Application - China Antiretroviral Therapy Sales, 2022-2027
5.3.3 By Application - China Antiretroviral Therapy Sales Market Share, 2016-2027
5.4 By Application - China Antiretroviral Therapy Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Gilead
6.1.1 Gilead Corporation Information
6.1.2 Gilead Overview
6.1.3 Gilead Antiretroviral Therapy Sales and Revenue in China Market (2016-2021)
6.1.4 Gilead Antiretroviral Therapy Product Description
6.1.5 Gilead Recent Developments
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Corporation Information
6.2.2 F. Hoffmann-La Roche Overview
6.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales and Revenue in China Market (2016-2021)
6.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Product Description
6.2.5 F. Hoffmann-La Roche Recent Developments
6.3 ViiV Healthcare
6.3.1 ViiV Healthcare Corporation Information
6.3.2 ViiV Healthcare Overview
6.3.3 ViiV Healthcare Antiretroviral Therapy Sales and Revenue in China Market (2016-2021)
6.3.4 ViiV Healthcare Antiretroviral Therapy Product Description
6.3.5 ViiV Healthcare Recent Developments
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Overview
6.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales and Revenue in China Market (2016-2021)
6.4.4 Boehringer Ingelheim Antiretroviral Therapy Product Description
6.4.5 Boehringer Ingelheim Recent Developments
6.5 Janssen Pharmaceuticals
6.5.1 Janssen Pharmaceuticals Corporation Information
6.5.2 Janssen Pharmaceuticals Overview
6.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales and Revenue in China Market (2016-2021)
6.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Product Description
6.5.5 Janssen Pharmaceuticals Recent Developments
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Overview
6.6.3 Mylan Antiretroviral Therapy Sales and Revenue in China Market (2016-2021)
6.6.4 Mylan Antiretroviral Therapy Product Description
6.6.5 Mylan Recent Developments
6.7 Abbvie
6.7.1 Abbvie Corporation Information
6.7.2 Abbvie Overview
6.7.3 Abbvie Antiretroviral Therapy Sales and Revenue in China Market (2016-2021)
6.7.4 Abbvie Antiretroviral Therapy Product Description
6.7.5 Abbvie Recent Developments
6.8 Bionor Pharma
6.8.1 Bionor Pharma Corporation Information
6.8.2 Bionor Pharma Overview
6.8.3 Bionor Pharma Antiretroviral Therapy Sales and Revenue in China Market (2016-2021)
6.8.4 Bionor Pharma Antiretroviral Therapy Product Description
6.8.5 Bionor Pharma Recent Developments
6.9 Vertex Pharmaceuticals
6.9.1 Vertex Pharmaceuticals Corporation Information
6.9.2 Vertex Pharmaceuticals Overview
6.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales and Revenue in China Market (2016-2021)
6.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Product Description
6.9.5 Vertex Pharmaceuticals Recent Developments
7 China Antiretroviral Therapy Production Capacity, Analysis
7.1 China Antiretroviral Therapy Production Capacity, 2016-2027
7.2 Antiretroviral Therapy Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Antiretroviral Therapy Supply Chain Analysis
9.1 Antiretroviral Therapy Industry Value Chain
9.2 Antiretroviral Therapy Upstream Market
9.3 Antiretroviral Therapy Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Antiretroviral Therapy Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Antiretroviral Therapy in China Market
Table 2. Top Antiretroviral Therapy Players in China Market, Ranking by Revenue (2019)
Table 3. China Antiretroviral Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Antiretroviral Therapy Revenue Share by Companies, 2016-2021
Table 5. China Antiretroviral Therapy Sales by Companies, (KG), 2016-2021
Table 6. China Antiretroviral Therapy Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Antiretroviral Therapy Price (2016-2021) & (USD/KG)
Table 8. Manufacturers Antiretroviral Therapy Product Type
Table 9. List of Tier 1 Antiretroviral Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Antiretroviral Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of NNRTIs
Table 12. Major Manufacturers of NRTI
Table 13. By Type - China Antiretroviral Therapy Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Antiretroviral Therapy Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Antiretroviral Therapy Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Antiretroviral Therapy Sales (KG), 2016-2021
Table 17. By Type - China Antiretroviral Therapy Sales (KG), 2022-2027
Table 18. By Application - China Antiretroviral Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Antiretroviral Therapy Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Antiretroviral Therapy Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Antiretroviral Therapy Sales (KG), 2016-2021
Table 22. By Application - China Antiretroviral Therapy Sales (KG), 2022-2027
Table 23. Gilead Corporation Information
Table 24. Gilead Description and Major Businesses
Table 25. Gilead Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 26. Gilead Antiretroviral Therapy Product
Table 27. Gilead Recent Developments
Table 28. F. Hoffmann-La Roche Corporation Information
Table 29. F. Hoffmann-La Roche Description and Major Businesses
Table 30. F. Hoffmann-La Roche Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 31. F. Hoffmann-La Roche Antiretroviral Therapy Product
Table 32. F. Hoffmann-La Roche Recent Developments
Table 33. ViiV Healthcare Corporation Information
Table 34. ViiV Healthcare Description and Major Businesses
Table 35. ViiV Healthcare Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 36. ViiV Healthcare Antiretroviral Therapy Product
Table 37. ViiV Healthcare Recent Developments
Table 38. Boehringer Ingelheim Corporation Information
Table 39. Boehringer Ingelheim Description and Major Businesses
Table 40. Boehringer Ingelheim Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 41. Boehringer Ingelheim Antiretroviral Therapy Product
Table 42. Boehringer Ingelheim Recent Developments
Table 43. Janssen Pharmaceuticals Corporation Information
Table 44. Janssen Pharmaceuticals Description and Major Businesses
Table 45. Janssen Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 46. Janssen Pharmaceuticals Antiretroviral Therapy Product
Table 47. Janssen Pharmaceuticals Recent Developments
Table 48. Mylan Corporation Information
Table 49. Mylan Description and Major Businesses
Table 50. Mylan Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 51. Mylan Antiretroviral Therapy Product
Table 52. Mylan Recent Developments
Table 53. Abbvie Corporation Information
Table 54. Abbvie Description and Major Businesses
Table 55. Abbvie Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 56. Abbvie Antiretroviral Therapy Product
Table 57. Abbvie Recent Developments
Table 58. Bionor Pharma Corporation Information
Table 59. Bionor Pharma Description and Major Businesses
Table 60. Bionor Pharma Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 61. Bionor Pharma Antiretroviral Therapy Product
Table 62. Bionor Pharma Recent Developments
Table 63. Vertex Pharmaceuticals Corporation Information
Table 64. Vertex Pharmaceuticals Description and Major Businesses
Table 65. Vertex Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 66. Vertex Pharmaceuticals Antiretroviral Therapy Product
Table 67. Vertex Pharmaceuticals Recent Developments
Table 68. Antiretroviral Therapy Production Capacity (KG) of Key Manufacturers in China Market, 2019-2021 (KG)
Table 69. China Antiretroviral Therapy Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Antiretroviral Therapy Market Opportunities & Trends in China Market
Table 71. Antiretroviral Therapy Market Drivers in China Market
Table 72. Antiretroviral Therapy Market Restraints in China Market
Table 73. Antiretroviral Therapy Raw Materials
Table 74. Antiretroviral Therapy Raw Materials Suppliers in China Market
Table 75. Typical Antiretroviral Therapy Downstream
Table 76. Antiretroviral Therapy Downstream Clients in China Market
Table 77. Antiretroviral Therapy Distributors and Sales Agents in China Market
List of FiguresFigure 1. Antiretroviral Therapy Product Picture
Figure 2. Antiretroviral Therapy Segment by Type
Figure 3. Antiretroviral Therapy Segment by Application
Figure 4. China Antiretroviral Therapy Market Overview: 2020
Figure 5. China Antiretroviral Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Antiretroviral Therapy Revenue, 2016-2027 (US$, Mn)
Figure 7. Antiretroviral Therapy Sales in China Market: 2016-2027 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Antiretroviral Therapy Revenue in 2020
Figure 9. NNRTIs Product Picture
Figure 10. NRTI Product Picture
Figure 11. Multiclass Combination Products Product Picture
Figure 12. Integrase Inhibitors Product Picture
Figure 13. By Type - China Antiretroviral Therapy Sales Market Share, 2016-2027
Figure 14. By Type - China Antiretroviral Therapy Revenue Market Share, 2016-2027
Figure 15. By Type - China Antiretroviral Therapy Price (USD/KG), 2016-2027
Figure 16. Hospital
Figure 17. Clinic
Figure 18. Other
Figure 19. By Application - China Antiretroviral Therapy Sales Market Share, 2016-2027
Figure 20. By Application - China Antiretroviral Therapy Revenue Market Share, 2016-2027
Figure 21. By Application - China Antiretroviral Therapy Price (USD/KG), 2016-2027
Figure 22. Gilead Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. F. Hoffmann-La Roche Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. ViiV Healthcare Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Boehringer Ingelheim Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Janssen Pharmaceuticals Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Mylan Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Abbvie Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Bionor Pharma Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Vertex Pharmaceuticals Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. China Antiretroviral Therapy Production Capacity (KG), 2016-2027
Figure 32. Antiretroviral Therapy Industry Value Chain
Figure 33. Marketing Channels